GB1421229A – Pharmaceutical compositions comprising ergot alkaloid and vitamins
– Google Patents
GB1421229A – Pharmaceutical compositions comprising ergot alkaloid and vitamins
– Google Patents
Pharmaceutical compositions comprising ergot alkaloid and vitamins
Info
Publication number
GB1421229A
GB1421229A
GB2361973A
GB2361973A
GB1421229A
GB 1421229 A
GB1421229 A
GB 1421229A
GB 2361973 A
GB2361973 A
GB 2361973A
GB 2361973 A
GB2361973 A
GB 2361973A
GB 1421229 A
GB1421229 A
GB 1421229A
Authority
GB
United Kingdom
Prior art keywords
pharmaceutical compositions
vitamins
ergot alkaloid
dihydroergotamine
vitamin
Prior art date
1972-05-17
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB2361973A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pierre Fabre SA
Original Assignee
Pierre Fabre SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
1972-05-17
Filing date
1973-05-17
Publication date
1976-01-14
1973-05-17
Application filed by Pierre Fabre SA
filed
Critical
Pierre Fabre SA
1976-01-14
Publication of GB1421229A
publication
Critical
patent/GB1421229A/en
Status
Expired
legal-status
Critical
Current
Links
Espacenet
Global Dossier
Discuss
Classifications
A—HUMAN NECESSITIES
A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
A61K31/00—Medicinal preparations containing organic active ingredients
A61K31/70—Carbohydrates; Sugars; Derivatives thereof
A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
Abstract
1421229 Medicines comprising dihydroergotamine PIERRE FABRE SA 17 May 1973 [17 May 1972] 23619/73 Heading A5B Pharmaceutical compositions for the treatment of circulatory disorders comprise dihydroergotamine or a salt thereof and one or more vitamin P-active compounds, e.g. trihydroxyethylrutine, hesperidin or methyl chalcone. A vitamin C-active compound may also be present. Oral and parenteral forms are mentioned.
GB2361973A
1972-05-17
1973-05-17
Pharmaceutical compositions comprising ergot alkaloid and vitamins
Expired
GB1421229A
(en)
Applications Claiming Priority (1)
Application Number
Priority Date
Filing Date
Title
FR7217754A
FR2184460B1
(en)
1972-05-17
1972-05-17
Publications (1)
Publication Number
Publication Date
GB1421229A
true
GB1421229A
(en)
1976-01-14
Family
ID=9098714
Family Applications (1)
Application Number
Title
Priority Date
Filing Date
GB2361973A
Expired
GB1421229A
(en)
1972-05-17
1973-05-17
Pharmaceutical compositions comprising ergot alkaloid and vitamins
Country Status (5)
Country
Link
US
(1)
US3887705A
(en)
BE
(1)
BE799649A
(en)
DE
(1)
DE2325070A1
(en)
FR
(1)
FR2184460B1
(en)
GB
(1)
GB1421229A
(en)
Families Citing this family (9)
* Cited by examiner, † Cited by third party
Publication number
Priority date
Publication date
Assignee
Title
US4167562A
(en)
*
1978-08-28
1979-09-11
Evers H Ray
Method and composition for treating arteriosclerosis
DE2935515A1
(en)
*
1979-09-03
1981-03-19
Fa. Dr. Willmar Schwabe, 7500 Karlsruhe
MEDICINAL PRODUCT
US4366145A
(en)
*
1981-06-24
1982-12-28
Sandoz, Inc.
Soft gelatin capsule with a liquid ergot alkaloid center fill solution and method of preparation
US5069911A
(en)
*
1985-02-05
1991-12-03
Sandoz Ltd.
Pharmaceutical 9,10-dihydrogenated ergot alkaloid containing compositions
WO1987006128A1
(en)
*
1986-04-07
1987-10-22
Clemetson Ab Charles
Catechin coated ascorbic acid and method
US4929640A
(en)
*
1988-04-04
1990-05-29
George D. McAdory
Medicaments intended for combined use in the improvement of lymphocyte function
IL91928A
(en)
*
1989-10-08
1994-07-31
Amrad Res & Dev
Pharmaceutical compositions containing prolactin
US20030181488A1
(en)
*
2002-03-07
2003-09-25
Boehringer Ingelheim Pharma Gmbh & Co. Kg
Administration form for the oral application of 3-[(2-{[4-(hexyloxycarbonylamino-imino-methyl)-phenylamino]-methyl}-1-methyl-1H-benzimidazol-5-carbonyl)-pyridin-2-yl-amino]-propionic acid ethyl ester and the salts thereof
US20060030620A1
(en)
*
2004-08-04
2006-02-09
Chia-Yu Chang
Method for treating and/or preventing ischemia/reperfusion injury
1972
1972-05-17
FR
FR7217754A
patent/FR2184460B1/fr
not_active
Expired
1973
1973-05-17
GB
GB2361973A
patent/GB1421229A/en
not_active
Expired
1973-05-17
BE
BE131201A
patent/BE799649A/en
unknown
1973-05-17
US
US361020A
patent/US3887705A/en
not_active
Expired – Lifetime
1973-05-17
DE
DE2325070A
patent/DE2325070A1/en
active
Pending
Also Published As
Publication number
Publication date
FR2184460A1
(en)
1973-12-28
BE799649A
(en)
1973-09-17
US3887705A
(en)
1975-06-03
FR2184460B1
(en)
1975-06-20
DE2325070A1
(en)
1973-11-29
Similar Documents
Publication
Publication Date
Title
ES413944A1
(en)
1976-06-01
Drugs or medicines for influencing the central nervous system
NL183032C
(en)
1988-07-01
METHOD FOR PREPARING PHARMACEUTICALLY ACTIVE N-SUBSTITUTED 4,5,6,7-TETRAHYDROTHIENO-PYRIDINE DERIVATIVES, METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION AND PHARMACEUTICAL ARTICLE.
CA1005061A
(en)
1977-02-08
Process for the preparation of 3,5,6-tricarboxy-and 2,3,5,6-tetracarboxy-1,4-dihydropyridine derivatives
CA1016544A
(en)
1977-08-30
Process for the preparation of bicyclic derivatives of 1,4-dihydropyridine
IL42781A0
(en)
1973-10-25
Derivatives of (4'-(3" -indolyl)piperidino)alkylarylketones,process for preparing them and pharmaceutical compositions
IL37547A0
(en)
1971-11-29
Isoindoline derivatives,processes for their preparation and pharmaceutical preparations containing the same
CA973554A
(en)
1975-08-26
2,3,5,6-tetraaminopyridine and its acid salts and processes for its preparation
GB1421229A
(en)
1976-01-14
Pharmaceutical compositions comprising ergot alkaloid and vitamins
NL8601837A
(en)
1987-02-16
POLY-4-AMINOPYRROL-2-CARBOXAMIDODERIVATIVES, METHOD FOR THE PRODUCTION THEREOF, PHARMACEUTICAL PREPARATIONS CONTAINING THESE DERIVATIVES AND METHOD FOR THE PREPARATION OF THE PHARMACEUTICAL PREPARATIONS.
GB1491503A
(en)
1977-11-09
Method of preventing and treating thrombosis
IL75874A0
(en)
1985-11-29
Naphthyl analogs of mevalonolactone and derivatives thereof,their production and pharmaceutical compositions containing them
CS194774B2
(en)
1979-12-31
Process for preparing derivatives of 1,4-dihydropyridine suitable especially as antihypertensive and antianginar medicament
ES426664A1
(en)
1977-01-01
2-Substituted phenyl-s-triazolo[5,1-a] isoquinoline compounds
DE3670288D1
(en)
1990-05-17
MEDICINAL PRODUCTS CONTAINING DERIVATIVES OF PROLIN OR HYDROXYPROLIN.
ES8402819A1
(en)
1984-03-01
Derivatives of 3,3-dialkyl-indolin and of 3,3-alkylene-indolin, method for producing them and pharmaceutical preparations containing them
GB1500300A
(en)
1978-02-08
Pharmaceutical preparation for the treatment of circulatory disorders
CA960655A
(en)
1975-01-07
N(6)-aralkyl adenosine derivatives, process for their preparation and pharmaceutical compositions containing the same
GB1178012A
(en)
1970-01-14
A Method for the Production of Pyridine Derivatives
GB1118606A
(en)
1968-07-03
Compositions for the treatment of haemorrhoids
IE35711L
(en)
1972-04-12
Pharmaceutical compositions
SE398644B
(en)
1978-01-09
METHOD OF PREPARATION OF PHARMACEUTICAL ACTIVE 2,10-DICHLORO-12-METHYL- (2H-DIBENSO (D G)) 1,3) -DIOXOCIN DERIVATIVES
PT65083B
(en)
1977-09-14
Process for the preparation of 2-substituted 1,4-benzodiazepine derivatives
CA939353A
(en)
1974-01-01
Manufacture of 1,1'-disubstituted-4,4'-bipyridylium salts and related compounds
AU470779B2
(en)
1976-03-25
Novel 2-substituted 6,7-benzomorphan derivatives and salts thereof
IE33519B1
(en)
1974-07-24
Novel benzyl-hydrazide derivatives and a process for the manufacture thereof and novel benzylidene-hydrazide derivatives useful in said process
Legal Events
Date
Code
Title
Description
1976-05-26
PS
Patent sealed [section 19, patents act 1949]
1990-01-17
PCNP
Patent ceased through non-payment of renewal fee
